Alpha Mannosidosis Market Report 2023

Alpha Mannosidosis Global Market Report 2023 – By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy), By Indication (Type I, Type II, Type III), By End User (Hospitals, Speciality Clinics) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Alpha Mannosidosis Market

Proud Members Of

Alpha mannosidosis refers to a rare genetic disorder defined by the body's cells' inability to adequately break down specific groups of complex sugars. Numerous bodily organs and systems, including the central nervous system, are impacted by sugar buildup. The disease's effects might vary greatly from person to person.

The main types of therapy for alpha mannosidosis are bone marrow transplant (BMT), enzyme replacement therapy (ERT), peripheral blood stem cell transplantation (PBSCT) and gene therapy. A bone marrow transplant is a procedure in which dysfunctional marrow is replaced with healthy marrow. Enzyme replacement therapy includes replacing a defective enzyme in people who are lacking or deficient in that enzyme. Peripheral blood stem cell transplantation is a procedure in which the patient whose stem cells have been destroyed by disease or by radiation or high doses of anticancer drugs, receives healthy stem cells. Gene therapy is a procedure in which DNA is introduced to a patient to treat a genetic disease. The different types of indications include Type I, Type II and Type III and are implemented in a wide range of verticals such as hospitals and speciality clinics.

The global alpha mannosidosis market is segmented -

1) By Therapy Type: Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy

2) By Indication: Type I, Type II, Type III

3) By End-User: Hospitals, Speciality Clinics

The global alpha mannosidosis market size will grow from $10.59 billion in 2022 to $12.65 billion in 2023 at a compound annual growth rate (CAGR) of 19.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the alpha mannosidosis is expected to grow to $24.27 billion in 2027 at a CAGR of 17.7%.

The increasing investments in research are expected to contribute to the growth of the alpha mannosidosis market in the forecast period. Currently, in the alpha mannosidosis market, only one company has therapies for rare genetic diseases. However, several firms have products in the clinical stages, which will boost market demand in the forecast period. For instance, in 2020, the EU clinical trials database lists 39,219 clinical trials with a EudraCT protocol, 6,426 of which are clinical trials involving subjects under the age of 18. Therefore, the increasing investments in research fuel the growth of the alpha mannosidosis market.

Major players in the alpha mannosidosis market are Chiesi Farmaceutici S.p.A., Nuo Therapeutics, and Zymenex.

The advancements in treatment for alpha mannosidosis like pharmacological therapy are gaining traction in the alpha mannosidosis market. For instance, in 2018 – Chiesi Group, an international research-focused Healthcare company, announced that it has received a positive opinion recommending the marketing authorization of Velmanase Alfa, under the brand name Lamzede from the European Medicines Agency Committee for Medicinal Products for Human Use. Lamzede is an enzyme replacement therapy intended to provide or supplement natural alpha-mannosidase, an enzyme that helps with the degradation of mannose–rich oligosaccharides and thus prevents their accumulation in various tissues in the body.

North America was the largest region in the alpha mannosidosis market in 2022. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the alpha mannosidosis market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the alpha mannosidosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The alpha mannosidosis market includes revenues earned by entities by intellectual disability, skeletal abnormalities, hearing loss, and muscle weakness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The alpha mannosidosis market research report is one of a series of new reports from The Business Research Company that provides alpha mannosidosis market statistics, including alpha mannosidosis industry global market size, regional shares, competitors with a alpha mannosidosis market share, detailed alpha mannosidosis market segments, market trends and opportunities, and any further data you may need to thrive in the alpha mannosidosis industry. This alpha mannosidosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Alpha Mannosidosis Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Therapy Type

    6.3. Segmentation By Indication

    6.4. Segmentation By End-User

    7. Alpha Mannosidosis Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By Therapy Type

    7.2.1. Bone Marrow Transplant (BMT)

    7.2.2. Enzyme Replacement Therapy (ERT)

    7.2.3. Others

    7.3. Segmentation By Indication

    7.3.1. Type I

    7.3.2. Type II

    7.3.3. Type III

    7.4. Market Segmentation By End-User

    7.4.1. Hospitals

    7.4.2. Specialty Clinics

    8. Alpha Mannosidosis Market Trends And Strategies

    8.1. Enzyme Replacement Therapy

    8.2. Hematopoietic Stem Cell Transplantation (HSCT)

    8.3. Cisterna Magna Infusion

    8.4. Global Research Initiatives And Funding

    9. Impact Of COVID-19 On The Alpha Mannosidosis Market

    9.1. Introduction

    9.2. Impact On Research And Development Activities And Clinical Trials

    9.3. COVID-19 Impact On Treatment

    9.4. Impact On Patients And Healthcare Providers

    9.5. Future Outlook

    10. Global Alpha Mannosidosis Market Size And Growth

    10.1. Market Size

    10.2. Forecast Market Growth, 2020 –2030F, Value ($ Million)

    10.2.1. Drivers Of The Market 2020 – 2025

    10.2.2. Restraints On The Market 2020 – 2025

    11. Global Alpha Mannosidosis Market Segmentation

    11.1. Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    11.2. Global Alpha Mannosidosis Market, Segmentation By Indication, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    11.3. Global Alpha Mannosidosis Market, Segmentation By End-User, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    12. Alpha Mannosidosis Market, Regional And Country Analysis

    12.1. Global Alpha Mannosidosis Market, By Region, Historic and Forecast, 2020, 2025F-2030F, Value ($ Million)

    12.2. Global Alpha Mannosidosis Market, By Country, Historic and Forecast, 2020, 2025F-2030F, Value ($ Million)

    13. Asia-Pacific Alpha Mannosidosis Market

    13.1. Asia Pacific Alpha Mannosidosis Market Overview

    13.1.1. Region Information

    13.1.2. Market Information

    13.1.3. Impact Of COVID-19

    13.1.4. Background Information

    13.1.5. Government Initiatives

    13.1.6. Regulations

    13.1.7. Regulatory Bodies

    13.1.8. Major Associations

    13.1.9. Taxes Levied

    13.1.10. Corporate Tax Structure

    13.1.11. Investments

    13.1.12. Major Companies

    13.2. Asia-Pacific Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    13.3. Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    13.4. Asia-Pacific Alpha Mannosidosis Market: Country Analysis

    13.5. China Alpha Mannosidosis Market

    13.6. China Alpha Mannosidosis Market Overview

    13.6.1. Country Information

    13.6.2. Market Information

    13.6.3. Impact Of COVID-19

    13.6.4. Background Information

    13.6.5. Government Initiatives

    13.6.6. Regulations

    13.6.7. Regulatory Bodies

    13.6.8. Major Associations

    13.6.9. Taxes Levied

    13.6.10. Corporate Tax Structure

    13.6.11. Investments

    13.6.12. Major Companies

    13.7. China Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    13.8. China Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    13.9. India Alpha Mannosidosis Market

    13.10. India Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    13.11. India Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    13.12. Japan Alpha Mannosidosis Market

    13.13. Japan Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    13.14. Japan Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    13.15. Australia Alpha Mannosidosis Market

    13.16. Australia Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    13.17. Australia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    13.18. Indonesia Alpha Mannosidosis Market

    13.19. South Korea Alpha Mannosidosis Market

    13.20. South Korea Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    13.21. South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    14. Western Europe Alpha Mannosidosis Market

    14.1. Western Europe Alpha Mannosidosis Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. Impact Of COVID-19

    14.1.4. Background Information

    14.1.5. Government Initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investments

    14.1.12. Major Companies

    14.2. Western Europe Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    14.3. Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    14.4. Western Europe Alpha Mannosidosis Market: Country Analysis

    14.5. UK Alpha Mannosidosis Market

    14.6. UK Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    14.7. UK Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    14.8. Germany Alpha Mannosidosis Market

    14.9. Germany Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    14.10. Germany Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    14.11. France Alpha Mannosidosis Market

    14.12. France Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    14.13. France Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    15. Eastern Europe Alpha Mannosidosis Market

    15.1. Eastern Europe Alpha Mannosidosis Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. Impact Of COVID-19

    15.1.4. Background Information

    15.1.5. Government Initiatives

    15.1.6. Regulations

    15.1.7. Regulatory Bodies

    15.1.8. Major Associations

    15.1.9. Taxes Levied

    15.1.10. Corporate Tax Structure

    15.1.11. Investments

    15.1.12. Major Companies

    15.2. Eastern Europe Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    15.3. Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    15.4. Eastern Europe Alpha Mannosidosis Market: Country Analysis

    15.5. Russia Alpha Mannosidosis Market

    15.6. Russia Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    15.7. Russia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    16. North America Alpha Mannosidosis Market

    16.1. North America Alpha Mannosidosis Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. Impact of COVID-19

    16.1.4. Background Information

    16.1.5. Government Initiatives

    16.1.6. Regulations

    16.1.7. Regulatory Bodies

    16.1.8. Associations

    16.1.9. Taxes Levied

    16.1.10. Corporate Tax Structure

    16.1.11. Investments

    16.1.12. Major Companies

    16.2. North America Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    16.3. North America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    16.4. North America Alpha Mannosidosis Market: Country Analysis

    16.5. USA Alpha Mannosidosis Market

    16.6. USA Alpha Mannosidosis Market Overview

    16.6.1. Country Information

    16.6.2. Market Information

    16.6.3. Impact of COVID-19

    16.6.4. Background Information

    16.6.5. Government Initiatives

    16.6.6. Regulations

    16.6.7. Regulatory Bodies

    16.6.8. Associations

    16.6.9. Taxes Levied

    16.6.10. Corporate Tax Structure

    16.6.11. Investments

    16.6.12. Major Companies

    16.7. USA Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    16.8. USA Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    17. South America Alpha Mannosidosis Market

    17.1. South America Alpha Mannosidosis Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Impact of COVID-19

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. South America Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    17.3. South America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    17.4. South America Alpha Mannosidosis Market: Country Analysis

    17.5. Brazil Alpha Mannosidosis Market

    17.6. Brazil Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    17.7. Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    18. Middle East Alpha Mannosidosis Market

    18.1. Middle East Alpha Mannosidosis Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Impact Of COVID-19

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes Levied

    18.1.10. Corporate Tax Structure

    18.1.11. Investments

    18.1.12. Major Companies

    18.2. Middle East Alpha Mannosidosis Market, Forecast Market Growth, 2020 –2030F, Value ($ Million)

    18.3. Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, Value ($ Million)

    19. Africa Alpha Mannosidosis Market

    19.1. Africa Alpha Mannosidosis Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Impact of COVID-19

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Taxes Levied

    19.1.10. Corporate Tax Structure

    19.1.11. Investments

    19.1.12. Major Companies

    20. Global Alpha Mannosidosis Market Competitive Landscape

    20.1. Company Profiles

    20.2. Chiesi Farmaceutici S.p.A.

    20.2.1. Company Overview

    20.2.2. Products And Services.

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    21. Key Mergers And Acquisitions In The Alpha Mannosidosis Market

    21.1. Sanofi Acquired Kadmon

    21.2. Jasper Therapeutics Reverse Merger with Amplitude Healthcare Acquisition Corp

    21.3. Albumedix Ltd. Collaboration With Cell and Gene Therapy Catapult

    21.4. Elli Lilly And Company Acquired Prevail Therapeutics

    21.5. Chiesi Farmaceutici Acquired Rights to Ferriprox®

    21.6. Vertex Pharmaceuticals Incorporation Acquired Semma Therapeutics

    21.7. Merck Merged With (MoU) GenScript

    21.8. Pfizer Acquired Vivet Therapeutics

    22. Alpha Mannosidosis Market Pipeline Analysis

    23. Alpha Mannosidosis Market Opportunities And Strategies

    23.1. Global Alpha Mannosidosis Market In 2025 – Countries Offering Most New Opportunities

    23.2. Global Alpha Mannosidosis Market In 2025 – Segments Offering Most New Opportunities

    23.3. Global Alpha Mannosidosis Market In 2025 – Growth Strategies

    23.3.1. Market Trend Based Strategies

    23.3.2. Competitor Strategies

    24. Alpha Mannosidosis Market, Conclusions And Recommendations

    24.1. Conclusions

    24.2. Recommendations

    24.2.1. Product

    24.2.2. Place

    24.2.3. Price

    24.2.4. Promotion

    24.2.5. People

    25. Appendix

    25.1. Market Data Sources

    25.2. Research Methodology

    25.3. Currencies

    25.4. Research Inquiries

    25.5. The Business Research Company

    25.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 2: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 5: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 6: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 7: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 8: Global Alpha Mannosidosis Market, By Region, Historic and Forecast, 2020, 2025F-2030F, %
  • Table 9: Global Alpha Mannosidosis Market, By Region, Historic and Forecast, 2020, 2025F-2030F, $ Million
  • Table 10: Global Alpha Mannosidosis Market, By Country, Historic and Forecast, 2020, 2025F-2030F, %
  • Table 11: Global Alpha Mannosidosis Market, By Country, Historic and Forecast, 2020, 2025F-2030F, $ Million
  • Table 12: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals
  • Table 13: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 14: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 15:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 17: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 18: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 19: Asia-Pacific Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 20: Asia-Pacific Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 21: Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 22: Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 23: China Vaccine Market, COVID-19 Vaccines Approvals
  • Table 24:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 25: China, Population By Age Group, 2015-2025, Thousands
  • Table 26: China GDP Per Capita, 2015-2020, $
  • Table 27: China, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 28: China Alpha Mannosidosis Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 29: China Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 30: China Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 31: China Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 32: India Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 33: India Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 34: India Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 35: Japan Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 36: Japan Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 37: Japan Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 38: Australia Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 39: Australia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 40: Australia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 41: South Korea Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 42: South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 43: South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 44: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
  • Table 45: Western Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 46:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 47:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 48: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 49: Western Europe GDP Per Capita, 2015-2020, $
  • Table 50: Western Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 51: Western Europe Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 52: Western Europe Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 53: Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 54: Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 55: UK Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 56: UK Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 57: UK Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 58: Germany Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 59: Germany Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 60: Germany Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 61: France Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 62: France Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 63: France Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 64: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
  • Table 65: Eastern Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 66:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 67:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 68: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 69: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 70: Eastern Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 71: Eastern Europe Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 72: Eastern Europe Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 73: Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 74: Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 75: Russia Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 76: Russia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 77: Russia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 78: North America Vaccine Market, COVID-19 Vaccines Approvals
  • Table 79: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 80:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 81:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 82: North America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 83: North America GDP Per Capita, 2015-2020, $
  • Table 84: North America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 85: North America Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 86: North America Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 87: North America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 88: North America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 89: USA Vaccine Market, COVID-19 Vaccines Approvals
  • Table 90:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 91: USA, Population By Age Group, 2015-2025, Thousands
  • Table 92: USA GDP Per Capita, 2015-2020, $
  • Table 93: USA Home, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 94: USA Alpha Mannosidosis Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 95: USA Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 96: USA Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 97: USA Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 98: South America Vaccine Market, COVID-19 Vaccines Approvals
  • Table 99: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 100:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 101:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 102: South America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 103: South America GDP Per Capita, 2015-2020, $
  • Table 104: South America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 105: South America Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 106: South America Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 107: South America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 108: South America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 109: Brazil Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 110: Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 111: Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 112: Middle East Vaccine Market, COVID-19 Vaccines Approvals
  • Table 113: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 114:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 115:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 116: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 117: Middle East GDP Per Capita, 2015-2020, $
  • Table 118: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 119: Middle East Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 120: Middle East Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Table 121: Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Table 122: Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, $ Million
  • Table 123: Africa Vaccine Market, COVID-19 Vaccines Approvals
  • Table 124: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 125:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 126:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 127: Africa, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 128: Africa GDP Per Capita, 2015-2020, $
  • Table 129: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
  • Table 130: Africa Alpha Mannosidosis Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 131: Global Alpha Mannosidosis Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 132: Chiesi Farmaceutici S.p.A. – Financial Overview, 2016 - 2020, $ Billion
  • Table 133: Global Alpha Mannosidosis Market, Pipeline Analysis
  • Table 134: Global Alpha Mannosidosis Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 135: Global Alpha Mannosidosis Market Size Gain ($ Million), Segmentation By Therapy Type, 2020 – 2025
  • Table 136: Global Alpha Mannosidosis Market Size Gain ($ Million), Segmentation By Indication, 2020 – 2025
  • Table 137: Global Alpha Mannosidosis Market Size Gain ($ Million), Segmentation By End-User, 2020 – 2025
  • Table 138: Alpha Mannosidosis- Market Data Sources

List Of Figures

    Figure 1: Global Alpha Mannosidosis Market Segmentation By Therapy Type
  • Figure 2: Global Alpha Mannosidosis Market Segmentation By Indication
  • Figure 3: Global Alpha Mannosidosis Market Segmentation By End-User
  • Figure 4: Global Alpha Mannosidosis Market, Forecast, 2020 –2030F, $ Million
  • Figure 5: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 6: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 7: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 8: Global Alpha Mannosidosis Market, By Region, Historic and Forecast, 2020, 2025F-2030F, %
  • Figure 9: Global Alpha Mannosidosis Market, By Country, Historic and Forecast, 2020, 2025F-2030F, %
  • Figure 10: Asia-Pacific Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 11: Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 12: China Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 13: China Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 14: India Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 15: India Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 16: Japan Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 17: Japan Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 18: Australia Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 19: Australia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 20: South Korea Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 21: South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 22: Western Europe Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 23: Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 24: UK Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 25: UK Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 26: Germany Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 27: Germany Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 28: France Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 29: France Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 30: Eastern Europe Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 31: Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 32: Russia Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 33: Russia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 34: North America Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 35: North America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 36: USA Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 37: USA Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 38: South America Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 39: South America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 40: Brazil Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 41: Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 42: Middle East Alpha Mannosidosis Market, Forecast, 2020 – 2030F, $ Million
  • Figure 43: Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic And Forecast, 2020, 2025F-2030F, %
  • Figure 44: Global Alpha Mannosidosis Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 45: Chiesi Farmaceutici S.p.A.– Financial Overview, 2016 – 2020, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report